Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
Proactive Investors Australia
Home
Proactive Investors Australia
November 16, 2020
Published by
Dominic Burg
on
November 16, 2020
Categories
Cellmid implements three-year growth strategy for product revenue and distribution
October 26, 2020
Published by
Dominic Burg
on
October 26, 2020
Categories
Cellmid optimistic revenue will continue to grow in the months ahead
October 22, 2020
Published by
Dominic Burg
on
October 22, 2020
Categories
Cellmid renews board to align with consumer health growth strategy
July 10, 2020
Published by
Tiffany McMillan
on
July 10, 2020
Categories
Cellmid signs exclusive distribution agreement for SARS-CoV-2 laboratory tests
March 31, 2020
Published by
Tiffany McMillan
on
March 31, 2020
Categories
Cellmid will have rapid diagnostic test for COVID-19 available by early April, shares hit new high
February 27, 2020
Published by
Tiffany McMillan
on
February 27, 2020
Categories
Cellmid sees growth in revenue from new distribution channels
February 5, 2020
Published by
Tiffany McMillan
on
February 5, 2020
Categories
Cellmid moves closer to evolis anti-hair loss patent in China
January 6, 2020
Published by
Tiffany McMillan
on
January 6, 2020
Categories
Cellmid granted key midkine antibody patents in US and Europe
December 19, 2019
Published by
Tiffany McMillan
on
December 19, 2019
Categories
Cellmid takes on aging with both consumer products and pharmaceuticals
Prev page
1
2
3
4
5
6
7
8
9
Next page